Pharmaceuticals

Cancer Therapy Market Outlook 2026–2030 Exploring Growth Opportunities

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Cancer Therapy Market Over The 2026–2030 Period?

The cancer therapy market size has experienced rapid expansion in recent years. It is projected to increase from $210.44 billion in 2025 to $232.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. This historical growth can be attributed to factors such as rising cancer incidence, increased chemotherapy adoption, improvements in hospital oncology infrastructure, the expansion of radiation therapy, and an aging population.

The cancer therapy market size is expected to experience substantial growth in the upcoming years, expanding to $342.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. This growth during the forecast period can be attributed to factors such as biomarker-driven therapies, the expansion of the immuno-oncology pipeline, the adoption of precision medicine, rising healthcare expenditure, and improved early cancer detection. Prominent trends within this period include the rapid embrace of immunotherapy, the proliferation of targeted cancer treatments, the broadening scope of precision oncology, an increased reliance on combination therapies, and a shift towards personalized treatment protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

What Underlying Factors Are Accelerating The Growth Of The Cancer Therapy Market?

The escalating incidence of cancer is anticipated to fuel the expansion of the cancer therapy market moving forward. Cancer describes a collection of illnesses defined by the unchecked proliferation and dispersal of irregular cells within the body. The primary reason for the rise in cancer is increased exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy holds a critical position in addressing the increasing occurrence of cancer by treating existing cases, boosting survival rates, and slowing down disease advancement. For example, in February 2024, data from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that global cancer incidence will surpass 35 million new cases by 2050, indicating a 77% rise from the estimated 20 million cases recorded in 2022. Hence, the increasing prevalence of cancer is propelling the cancer therapy market.

How Is The Cancer Therapy Market Segmented Across Key Categories?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

Which Upcoming Trends Are Expected To Influence The Cancer Therapy Market?

Major companies within the cancer therapy market are concentrating on creating novel treatments, such as immuno-oncology drugs, to boost treatment efficacy by harnessing the body’s immune system to identify and destroy cancer cells. Immuno-oncology drugs are a class of cancer therapies designed to stimulate or enhance the body’s own immune system to recognize and attack cancer cells more proficiently. For instance, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab in India, which is the first and only immuno-oncology medication authorized for the treatment of nasopharyngeal cancer. This launch provides a new, targeted treatment option for patients suffering from this rare and aggressive cancer, potentially improving outcomes through advanced immune system engagement. The availability of toripalimab in India underscores Dr. Reddy’s commitment to expanding access to cutting-edge cancer therapies in underserved areas.

Who Are The Dominant Players Shaping The Cancer Therapy Market Landscape?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Read the full cancer therapy market report here:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Is Projected To Dominate The Cancer Therapy Market During The Forecast Period?

North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cancer Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

Browse Through More Reports Similar to the Global Cancer Therapy Market 2026, By The Business Research Company

Oncology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Blood Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-drug-discovery-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795